Skip to main content

Table 4 Clinical outcomes

From: Effect of enteral diet enriched with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in patients with sepsis-induced acute respiratory distress syndrome

Variable

Study group ( n= 23)

Control group ( n= 23)

Hazard ratio (95% CI)

p value

Duration of MV

  

1.663 (0.856–3.231)a

0.115

Mean (SE, 95% CI) days

13.61 (1.00, 11.66–15.56)

17.77 (1.81, 14.21–21.33)

  

Median (SE, 95% CI) days

14 (2.38, 9.34–18.66)

17 (2.23, 12.64–21.37)

  

Ventilator-free daysb (median, IQR)

14 (11–18)

11 (3–16)

 

0.172

Duration of ICU stay

  

2.182 (1.125–4.231)a

0.015

Mean (SE, 95% CI) days

17.6 3 (1.70, 14.30–20.97)

25.87 (2.6, 20.81–30.94)

  

Median (SE, 95% CI) days

15 (3.19, 8.74–21.26)

24 (1.82, 20.44–27.56)

  

ICU-free daysc (median, IQR)

13 (0–17)

4 (0–8)

 

0.028

Support free daysd

    

Renal replacement therapy, day

21 (0–24) (n = 7)

23 (14–25) (n = 7)

 

0.318

Catecholamine, day

26 (17.25–27) (n = 16)

26 (18–27) (n = 14)

 

0.728

Nosocomial infections, n (%)

10 (43.5)

12 (52.2)

 

0.768

Mortality, n (%)

3 (13.0)

3 (13.0)

 

1.000

  1. CI confidence interval, MV mechanical ventilation, SE standard error, IQR interquartile range, ICU intensive care unit. aThe hazard ratio was calculated with the use of Cox proportional-hazards model; bVentilator free days were defined as the number of days between successful weaning from mechanical ventilation and day 28. cICU-free days were defined as the number of days between successful discharge from ICU and day 28; dSupport free days were defined as the number of days between the last day supported and day 28.